Search clinical trials for: Alferon LDO

Total 1305 results

AIM ImmunoTech Inc.

Terminated

A Randomized, Dose-ranging Study of Alferon LDO in Asymptomatic HIV+ Subjects

HIV Infections

United States
AIM ImmunoTech Inc.

Completed

Study of Alferon® LDO (Low Dose Oral) in Normal Volunteers

Severe Acute Respiratory Syndrome

Hong Kong
LEO Pharma

Completed

LEO 32731 for the Treatment of Moderate to Severe Psoriasis Vulgaris

Psoriasis Vulgaris

Germany
Duke University

Completed

Microvascular and Fibrosis Imaging Study

Autoimmune Diseases | Chronic Graft Versus Host Disease | Sickle Cell Disease

United States
LEO Pharma

Completed

A Trial to Investigate the Safety, Tolerability, and Drug Levels in Blood After Single and Multiple Doses of LEO 32731 in Healthy People

Healthy

United Kingdom
LEO Pharma

Completed

Pharmacokinetics of LEO 43204 Gel in Actinic Keratosis Administered Under Maximal Use Conditions

Actinic Keratosis

United States
LEO Pharma

Completed

LEO 124249 Ointment in the Treatment of Alopecia Areata

Alopecia Areata

United States
LEO Pharma

Completed

Safety and Tolerability of LEO 138559 in Healthy Subjects and Subjects With Atopic Dermatitis

Atopic Dermatitis

United Kingdom
LEO Pharma

Completed

A Clinical Study to Evaluate the Sensitizing Potential of LEO 43204 Gel

Actinic Keratosis

United States
Emory University
Kaneka Medical America LLC

Completed

Effects of Low-density Lipoprotein (LDL) Apheresis on Inflammatory and Lipid Markers (INFLAME)

Familial Hypercholesterolemia

United States
St. Louis University
Lucerno Dynamics Limited Liability Company (LLC)

Completed

Patterns and Prevalence of FDG Extravasation in PET/CT Scans (Lucerno device)

Intravenous Infiltration

United States
LEO Pharma

Completed

An Explorative Trial Evaluating the Effect of LEO 32731 Cream in Adults With Mild to Moderate Atopic Dermatitis (AD)

Atopic Dermatitis

Germany
Materia Medica Holding

Completed

Efficacy of Anaferon for Children in the Treatment of Influenza and Acute Respiratory Viral Infections in Children

Influenza and Acute Respiratory Viral Infections

Russian Federation, Belarus, Ukraine
Shanghai Zhongshan Hospital

Recruiting

PDO/PDO-TIL/PDOTS for Drug Screen

Liver Cancer | Metastatic Liver Cancer

China
LEO Pharma

Completed

Proof of Concept, Twice Daily Applications of LEO 124249 Ointment in the Treatment of Chronic Hand Eczema

Hand Eczema

Germany
LEO Pharma

Terminated

Safety, Tolerability and Pharmacokinetics of LEO 29102 Cream in Atopic Dermatitis.

Atopic Dermatitis

Germany
Balt Extrusion

Completed

Endovascular Treatment of Wide Neck Intracranial Aneurysms With the LEO + Stent : The LEO + II Cohort Study

Intracranial Aneurysm
LEO Pharma

Completed

A Safety, Tolerability and Pharmacokinetic Study of LEO 29102 in Subjects With Atopic Dermatitis

Atopic Dermatitis

Netherlands
Efferon JSC

Recruiting

Selective Lipopolysaccharide Hemosorption in Maternal Sepsis (MINERVA)

Maternal sepsIs

Russian Federation
Efferon JSC

Completed

Hemoperfusion With the Efferon CT Extracorporeal Adsorbers in Patients With Severe Covid-19

COVID-19

Russian Federation
JW Pharmaceutical
LEO Pharma

Completed

Trial to Assess the Efficacy and Safety of LEO 152020 in Adult Patients With Cholinergic Urticaria

Cholinergic Urticaria

Germany
LEO Pharma

Completed

An Evaluation of LEO 138559 in Adults With Moderate to Severe Atopic Dermatitis.

Atopic Dermatitis

United States, Canada, Germany, Poland
LEO Pharma

Completed

A Trial to Evaluate Pharmacokinetics, Immunogenicity, Safety, and Tolerability of LEO 138559 in Healthy Japanese Subjects

Atopic Dermatitis

United States
LEO Pharma

Completed

LEO 90100 Twice Weekly Maintenance Regimen for Psoriasis Vulgaris

Psoriasis Vulgaris

United States, Canada, Germany, United Kingdom, France, Poland
Gamaleya Research Institute of Epidemiology and...
Research Institute of Influenza, Sankt-Peterburg, Russian Federation

Completed

A Double-blind Randomized Placebo-controlled Study of Safety and Immunogenicity of GamEvac-Lyo

Healthy Volunteers

Russian Federation
LEO Pharma

Completed

A Study of Increasing Strengths, Safety and Efficacy of Two Formulas of LEO 43204 on the Face or the Chest in Patients With Actinic Keratosis

Actinic Keratosis

Canada, United States
Efferon JSC

Recruiting

Combination of Cytokine Hemosorption and High-volume Hemofiltration in Acute Pancreatitis

Acute Pancreatitis Without Necrosis or Infection

Russian Federation
Materia Medica Holding

Completed

Clinical Trial of Efficacy and Safety of Anaferon in the Treatment of Acute Respiratory Viral Infections

Acute Respiratory Viral Infections

Russian Federation
Nanfang Hospital of Southern Medical University

Recruiting

Dual-Port Laparoscopic Distal Gastrectomy for Gastric Cancer

Gastric Cancer

China
LEO Pharma

Completed

Safety of LEO 43204 for Actinic Keratosis Applied on Face/Chest, Scalp and Trunk/Extremities, Respectively

Actinic Keratosis

United States
University of California, Davis

Completed

Lido Workset Study

Multiple Sclerosis

United States
LEO Pharma

Terminated

Efficacy and Safety of Delgocitinib Cream in Discoid Lupus Erythematosus.

Discoid Lupus Erythematosus

United States, France, Germany, Denmark
Dompé Farmaceutici S.p.A

Completed

A Single Dose Study About the Influence of Food on the Oral Bioavailability of Ladarixin Capsule in Healthy Volunteers

no Condition

Switzerland
Lars Wik
Jon Erik Steen Hansen; Unai Irusta Zarandona; Elisabete Aramendi; Erik Alonso; Simone... and other collaborators

Completed

AutoPulse Compared With Manual Technique for OHCA Patients on Outcome and CPR Process.

Cardiac Arrest | Out-Of-Hospital Cardiac Arrest

Norway
LEO Pharma

Completed

LEO 29102 Single and Multiple Dose Study by Dermal Application

Atopic Dermatitis

United Kingdom
LEO Pharma

Completed

Trial Twice Daily Application of LEO 124249 Ointment 30 mg/g in Treatment of Mild to Moderate Inverse Psoriasis

Inverse Psoriasis

Germany
Atatürk University

Completed

Behçet and LDH/Albumin

Disease Severity | Behcet's Disease | Albumin | Lactate Dehydrogenase

Turkey
LEO Pharma
ICON plc

Completed

A Single and Multiple Ascending-dose Trial of LEO 153339 in Healthy Adults

Healthy Volunteers

Netherlands
DeNova Research

Completed

Non-Surgical Rhinoplasty Using PDO Threads

Nasal Defect

United States
LEO Pharma

Completed

Multiple Dose Study With Incremental Dosing to Evaluate the Safety, Tolerability, and Pharmacokinetics of Oral Doses of LEO 32731 in Healthy Male Japanese Subjects.

Psoriasis Vulgaris

United Kingdom
Myriad Genetic Laboratories, Inc.
University of Minnesota

Completed

Bipolar Proteomic Assay Validation Study

Major Depressive Disorder, Bipolar I and Bipolar II

United States
LEO Pharma

Completed

Safety and Efficacy of Doses of LEO 43204 Once Daily for Two Consecutive Days on Full Balding Scalp in Subjects With Actinic Keratosis

Actinic Keratosis

United States
Sequenom, Inc.

Completed

Genetic Load and Phenotype in Aggressive AMD (RPED Genetics)

Age-related Macular Degeneration

United States
Fondazione IRCCS Ca' Granda, Ospedale Maggiore...

Recruiting

Setting a PERSONalized Outcome in ASthma: the PERSONAS Study. A Patient Driven Outcome (PDO) Study (PERSONAS)

Bronchial Asthma

Italy
Sunnybrook Health Sciences Centre

Terminated

Combined LDR Boost and HDR Whole Gland (Delight)

Carcinoma Prostate

Canada
LEO Pharma

Completed

LEO 27847 - Safety, Tolerability, Pharmacokinetic and Pharmacodynamic Study in Secondary Hyperparathyroidism Patients

Secondary Hyperparathyroidism

Germany, Poland
Clinical Research Center for End Stage Renal Disease...
Ministry of Health & Welfare, Korea

Completed

The Effects of Lowering Low-density Lipoprotein Cholesterol Levels to New Targets on Cardiovascular Complications in Peritoneal Dialysis Patients

Hypercholesterolemia

Korea, Republic of
LEO Pharma
Quintiles, Inc.

Completed

A Study Evaluating Skin Irritation, Phototoxicity and Safety After Administration of LEO 90105 on Intact Skin of Healthy Japanese Male Subjects

Healthy

Japan
LEO Pharma
Quintiles, Inc.

Completed

A Study Evaluating the Safety of LEO 90105 and Its Vehicle, After Multiple Administration on Intact Skin of Healthy Japanese Male Subjects

Healthy

Japan
Materia Medica Holding

Completed

Clinical Trial of Anaferon for Children Efficacy in Prevention of Influenza and Other ARVI

Preventive Medicine

Russian Federation, Uzbekistan

3

Subscribe